Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

OBJECTIVE: To determine the effect of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors, on biomarkers of nonalcoholic steatohepatitis (NASH) and fibrosis in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Hartman, Mark L., Sanyal, Arun J., Loomba, Rohit, Wilson, Jonathan M., Nikooienejad, Amir, Bray, Ross, Karanikas, Chrisanthi A., Duffin, Kevin L., Robins, Deborah A., Haupt, Axel
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2020
Matèries:
Novel Communications in Diabetes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245348/
https://ncbi.nlm.nih.gov/pubmed/32291277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1892
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars